A retrospective analysis of second-line chemotherapy for malignant pleural mesothelioma (MPM).

7040 Background: Chemotherapy is the only option for MPM. Cisplatin + pemetrexed became the standard in the first-line (FL), while the role of a second-line (SL) remains controversial. Methods: We ...